Lifecare ASA (LIFE): Invitation to presentation of Q1 2025 results and strategic update

09 May 2025 07:00 CEST

Lifecare ASA will release its results for the first quarter of 2025 on
Thursday, 15 May 2025 at 07:00 a.m. CEST. The company will host a presentation
of the results and provide a strategic update on the path to commercialization
at 10:00 a.m. the same day.

Lifecare ASA hereby invites you to the presentation of the first quarter 2025
results, including a strategic update on the path to commercialization.

Venue: Hotel Continental, Stortingsgaten 24/26, 0117 Oslo, Norway.
Date: Thursday 15 May
Time: 10:00 a.m. CEST

The results will be presented in English and broadcast live via webcast,
followed by a Q&A session. Participants will be able to submit questions
online throughout the session.

To access the webcast Join the Teams-meeting here.
(https://eur04.safelinks.protection.outlook.com/ap/t-59584e83/?url=https%3A%2F%2
Fteams.microsoft.com%2Fl%2Fmeetup-join%2F19%253ameeting_MjIyZDU1NGMtNWI1ZS00NDg3
LWJiYTYtYzRjODA4ZTgyZWVm%2540thread.v2%2F0%3Fcontext%3D%257B%2522Tid%2522%253A%2
5224cbfea0a-b872-47f0-b51c-1c64953c3f0b%2522%252C%2522Oid%2522%253A%25222c74671d
-f476-4659-b75b-ac80453ff4ee%2522%252C%2522IsBroadcastMeeting%2522%253Atrue%252C
%2522role%2522%253A%2522a%2522%257D%26btype%3Da%26role%3Da&data=05|02|asle.wings
ternes%40lifecare.no|a24ca83399494f204e0308dd8e192bd8|c5fbb1c64eb045db9f3c6e20eb
cd710e|0|0|638822960948667195|Unknown|TWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOi
IwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D|0|||&sdata=E2K0tw
3Zzk0eKOEYt%2B4uMir%2BeKu0fYDTFhs28lq7R3w%3D&reserved=0)

A recording of the webcast will be available on our website immediately after
the event.

Following the presentation, Lifecare invites participants to 1:1 meetings with
CEO Joacim Holter and CFO Renete Kaarvik.
To register for physical attendance and to schedule a 1:1 meeting, please
contact: kristin.samuelsen@dnb.no.

About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring ("CGM") systems to market.
Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor
technology is suitable for identifying and monitoring the occurrence of a wide
range of analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

More information:
Access the news on Oslo Bors NewsWeb site

645863_Lifecare ASA (LIFE)- Invitation to presentation of Q1 2025 results and strategic update.pdf